Perspectives
Featured Topics
Lead story
Other featured articles
-
Legalizing Marijuana, once a Pipe Dream on Capitol Hill, Takes an Important Step Forward
Rosalie Liccardo Pacula writes about strengths and weakness in the MORE Act along with additional policy ideas that could strengthen regulation and better protect consumers.
Posted in -
Will the Rebate Rule need Extra Innings?
The publication of the final rebate rule is an important milestone in this administration’s drug pricing journey. However, many challenges remain.
-
Election Polls Are More Accurate if They ask Participants How Others Will Vote
Traditional polls ask people whom they would vote for if the election were today, or for the percent chance that they might vote for particular candidates. But asking people about the political preferences of social circles and communities might yield more accurate results.
Posted in -
Understanding The Latest ACO “Savings”: Curb Your Enthusiasm And Sharpen Your Pencils—Part 2
In this post, the authors lay out key considerations for improving the MSSP over the long haul with the objective of helping get a repeatedly derailed conversation back on track.
Posted in
ADDITIONAL Perspectives
-
Understanding The Latest ACO “Savings”: Curb Your Enthusiasm And Sharpen Your Pencils—Part 1
Did the MSSP save Medicare $1.2 billion in 2019? No—not even close. Might the true net savings be close to zero? Quite possibly.
Categorized in -
Approving the Pfizer Vaccine Would, Finally, Mark the End of the Beginning
The news from Pfizer suggests we may be at the end of the beginning of the pandemic. We now have even more reason to redouble our pandemic control and mitigation efforts, so that we can limit the disability and death from new infections until vaccines become available.
Categorized in -
The COVID-19 Vaccines Are Coming. Here’s How They Should Be Rolled Out
Well before Operation Warp Speed delivers products en masse, we need to be prepared to distribute them effectively.
Categorized in -
Podcast: Essentially Medicine
Jakub Hlavka discusses numerous approaches to increase access to cell- and gene-therapies and how political will is essential to realize improvements in healthcare on the Essentially Medicine podcast.
Categorized in -
For the Sake of Kidney Patients, Vote No on Proposition 23
As a kidney doctor and health policy researcher, I am appalled that patients have become a bargaining chip in a game that could result in massive dialysis shortages, increased costs, and death.
Categorized in -
Free COVID-19 Vaccines: Not Enough to Guarantee Acceptance, Especially Among Black Americans
The researchers find cost does matter when estimating willingness to get a COVID-19 vaccine, but it isn’t the whole story.
Categorized in